// App-Quantinova.ai

P729 : A ‘real-world’ retrospective multi-centre study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis

Researchers

Presenter

  • V Kronsten

Principal Investigators

  • M Colwill

  • S Nayeemuddin

  • J Limdi

  • C Selinger

  • G Scott

  • L Al-Hillawi

  • S Salehi

  • P Blaker

  • G Chung-Faye

  • A Kent

  • P Dubois

  • B Hayee

Medical Centers

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Department of Gastroenterology, The Pennine Acute Hospitals NHS Trust, Manchester, UK

  • Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom

  • Department of Clinical Haematology, Leeds Teaching Hospitals NHS Trust, Leeds,

  • Department of Gastroenterology, East Kent Hospital University Foundation Trust, Margate, UK

  • Department of Gastroenterology, Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • Infliximab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved